As the COO and Co-Founder of VegaX Holdings (“VegaX”), Natasha is an experienced marketing, strategy, and M&A professional with over 10+ years of demonstrated leadership through key strategic roles at Fortune100 companies. Recently recognized as “Female Executive of the Year” and “Female Entrepreneur of the Year” at the Stevie Women in Business Awards, she holds an MBA from The Pennsylvania State University and has successfully led the company to secure numerous awards globally such as, 2018 “Startup of the Year,” NextMoney Global FinTech Finals, HFM Technology “Best FinTech Solution for Hedge Funds.” She most recently led the launch of Konstellation, DM’s blockchain development and consulting division, which was awarded its first accolade: “Best Blockchain Technology Provider” in the 2019 Wealth Management.com Industry Awards. With a passion for learning, business development, diversity and inclusion, financial literacy, and technology, Natasha continues to pioneer the need for change in financial services industry via fintech solutions.
Now she is focused on using her experience in fintech to build the next generation of investment strategies and indices with digital asset management firm, VegaX Holdings: The ‘BlackRock’ of Crypto-Assets.
Did you know?
Gilberto Loureiro grew up inspecting fabrics in a Portuguese textile factory. With Smartex, he and co-founders Antonio Rocha and Paulo Ribeiro are eliminating textile defects—and their enormous cost both to manufacturers and the environment.
Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.
To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.
In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.
In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.
It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.
Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.